© 2020 MJH Life Sciences and OncLive. All rights reserved.
June 23, 2020
Stuart L. Goldberg, MD, discusses financial toxicities faced in hematology.
April 02, 2018
Stuart L. Goldberg, MD, hematologist, John Theurer Cancer Center, discusses the use of 4 FDA-approved agents for patients with acute myeloid leukemia (AML) with varying genetic alterations.
March 02, 2018
Stuart L. Goldberg, MD, chief medical officer, John Theurer Cancer Center, discusses precision medicine for patients with hematologic malignancies.